UNITED STATES NEWS

Rare cases of COVID returning pose questions for Pfizer pill

May 9, 2022, 11:20 AM
FILE - In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid table...

FILE - In this photo provided by Pfizer, a lab technician visually inspects COVID-19 Paxlovid tablet samples in Freiburg, Germany in December 2021. As more doctors prescribe Pfizer's powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. (Pfizer via AP, File)

(Pfizer via AP, File)

WASHINGTON (AP) — As more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug.

Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.

But experts say there is still much to be learned about the drug, which was authorized in December for adults at high risk of severe COVID-19 based on a study in which 1,000 adults received the medication.

WHY DO SOME PATIENTS SEEM TO RELAPSE?

Doctors have started reporting rare cases of patients whose symptoms return several days after completing Paxlovid’s five-day regimen of pills. That’s prompted questions about whether those patients are still contagious and should receive a second course of Paxlovid.

Last week, the Food and Drug Administration weighed in. It advised against a second round because there’s little risk of severe disease or hospitalization among patients who relapse.

Dr. Michael Charness reported last month on a 71-year-old vaccinated patient who saw his symptoms subside but then return, along with a spike in virus levels nine days into his illness.

Charness says Paxlovid remains a highly effective drug, but he wonders if it might be less potent against the current omicron variant. The $500 drug treatment was tested and OK’d based on its performance against the delta version of the coronavirus.

“The ability to clear the virus after it’s suppressed may be different from omicron to delta, especially for vaccinated people,” said Charness, who works for Boston’s VA health system.

Could some people just be susceptible to a relapse? Both the FDA and Pfizer point out that 1% to 2% of people in Pfizer’s original study saw their virus levels rebound after 10 days. The rate was about the same among people taking the drug or dummy pills, “so it is unclear at this point that this is related to drug treatment,” the FDA stated.

Some experts point to another possibility: The Paxlovid dose isn’t strong enough to fully suppress the virus. Andy Pekosz of Johns Hopkins University worries that could spur mutations that are resistant to the drug.

“We should really make sure we’re dosing Paxlovid appropriately because I would hate to lose it right now,” said Pekosz, a virologist. “This is one of the essential tools we have to help us turn the corner on the pandemic.”

HOW WELL DOES PAXLOVID WORK IN VACCINATED PEOPLE?

Pfizer tested Paxlovid in the highest-risk patients: unvaccinated adults with no prior COVID-19 infection and other health problems, such as heart disease and diabetes. The drug reduced their risk of hospitalization and death from 7% to 1%.

But that doesn’t reflect the vast majority of Americans today, where 89% of adults have had at least one shot. And roughly 60% of Americans have been infected with the virus at some point.

“That’s the population I care about in 2022 because that’s who we’re seeing — vaccinated people with COVID — so do they benefit?” asked Dr. David Boulware, a University of Minnesota researcher and physician.

There’s no clear answer yet for vaccinated Americans, who already have a hospitalization rate far below 1%.

That may come from a large, ongoing Pfizer study that includes high-risk vaccinated people. No results have been published; the study is expected to wrap up in the fall.

Pfizer said last year that initial results showed Paxlovid failed to meet the study’s goals of significantly resolving symptoms and reducing hospitalizations. It recently stopped enrolling anyone who’s received a vaccination or booster in the past year, a change Boulware says suggests those patients aren’t benefitting.

At a minimum, the preliminary data should be released to federal officials, Boulware said. “If the U.S. government is spending billions of dollars on this medicine, what’s the obligation to release that data so that they can formulate a good policy?”

CAN PAXLOVID BE USED TO HELP PREVENT COVID-19 INFECTION?

Pfizer recently reported that proactively giving Paxlovid to family members of people infected with COVID-19 didn’t significantly reduce their chances of catching it. But that’s not the end of the story. Pfizer is studying several other potential benefits of early use, including whether Paxlovid reduces the length and severity of COVID-19 among households.

“It’s a high bar to protect against infection but I’d love to see data on how Paxlovid did against severe disease because it may be more effective there,” said Pekosz.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Lifetime Windows & Doors

United States News

In this March 23, 2021, photo, a man leaves a bouquet on a police cruiser parked outside the Boulde...
Associated Press

Mass shooters exploited gun laws, loopholes before carnage

The suspects in the shootings at a Uvalde, Texas, elementary school and a Buffalo, New York, supermarket were both just 18, authorities say, when they bought the weapons used in the attacks — too young to legally purchase alcohol or cigarettes, but old enough to arm themselves with assault weapons. The Buffalo suspect was taken […]
11 hours ago
Eloise Castro, 75 a resident of Uvalde visits a memorial site to lay flowers and a candle in the to...
Associated Press

Official: Kids to 911 during siege: ‘Please send the police’

UVALDE, Texas (AP) — Nearly 20 officers stood in a hallway outside of the classrooms during this week’s attack on a Texas elementary school for more than 45 minutes before agents used a master key to open a door and confront a gunman, authorities said Friday. The on-site commander believed the gunman, 18-year-old Salvador Ramos, […]
11 hours ago
Associated Press

Upstate New York teachers put on leave after offensive texts

ROCHESTER, N.Y. (AP) — Several public school teachers in Rochester were put on leave after exchanging text messages that made “racist and demeaning” references to students, officials said Friday. The Democrat and Chronicle reported the teachers worked at Enrico Fermi School 17, which has a large percentage of Black and Hispanic students in pre-kindergarten through […]
11 hours ago
Associated Press

Iran seizes 2 Greek tankers in Persian Gulf, tensions spike

DUBAI, United Arab Emirates (AP) — Iran’s paramilitary Revolutionary Guard seized two Greek oil tankers on Friday in the Persian Gulf, just after Athens assisted the U.S. in seizing an Iranian oil tanker over alleged sanctions violations in the Mediterranean Sea. The Guard’s announcement comes as tensions remain high between Iran and the West over […]
11 hours ago
Associated Press

Lawyer will seek to move trial of Alabama jail escapee

FLORENCE, Ala. (AP) — A lawyer for an Alabama inmate who was the subject of a national manhunt after escaping with the apparent help of a jail official, said he will ask to move his trial to another city. Mark McDaniel, a lawyer representing Casey White, said he will seek a change of venue to […]
11 hours ago
Detroit firefighters clean up in front of Traffic Jam and Snug Restaurant,  after an overnight fire...
Associated Press

Blaze destroys landmark restaurant in Detroit’s Midtown

DETROIT (AP) — Fire destroyed a landmark restaurant and brewpub Friday in Midtown Detroit, but spared the neighboring Third Man Records store owned by musician Jack White as well as Shinola’s flagship watch store. No one was inside Traffic Jam & Snug at the time of the blaze and the restaurant was believed to be […]
11 hours ago

Sponsored Articles

...
Day & Night Air

Tips to lower your energy bill in the Arizona heat

Does your summer electric bill make you groan? Are you looking for effective ways to reduce your bill?
...
Arizona Division of Problem Gambling

Arizona Division of Problem Gambling provides exclusion solution for young sports bettors

Sports betting in Arizona opened a new world to young adults, one where putting down money on games was as easy as sending a text message.
...
SCHWARTZ LASER EYE CENTER

Key dates for Arizona sports fans to look forward to in April

April brings new beginnings in different ways for Arizona’s professional sports teams like the Suns and Diamondbacks.
Rare cases of COVID returning pose questions for Pfizer pill